![]() |
市场调查报告书
商品编码
1667642
男性用生殖医疗设备的全球市场:规模,占有率,趋势分析(2025年~2031年):MedCoreMen's Reproductive Health Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: Inflatable and Malleable Erectile Dysfunction Device Markets |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计到 2024 年全球男性生殖医疗设备市场价值将超过 2.89 亿美元。预计该市场将以 2.5% 的复合年增长率扩张,到 2031 年将达到 3.43 亿美元以上。
此市场与良性前列腺增生 (BPH) 和前列腺癌治疗密切相关。放射治疗引起的 ED 往往比根治性前列腺切除术 (RP) 引起的 ED 发生得晚。可充气和可塑性阴茎假体的技术创新正在增加。
本报告提供全球男性用生殖医疗设备市场相关调查,提供市场概要,以及各市场区隔,各地区趋势,竞争情形等资讯。
The global men's reproductive health device market was valued at over $289 million in 2024 and is projected to grow at a CAGR of 2.5%, reaching over $343 million by 2031.
Market Segments Covered:
Comprehensive Market Insights
Global Market Trends
Market Share Insights
Top Competitors in the Global Erectile Dysfunction Device Market (2024):
1 Boston Scientific
* Market leader offering the AMS 700(TM) MS Series (three-piece inflatable devices) and AMS Ambicor(R) (two-piece inflatable devices).
* Dominates the market following its 2018 acquisition of American Medical Systems (AMS).
2 Coloplast
* Second-largest competitor with the Titan(R) Inflatable Penile Prosthesis and Malleable Penile Prostheses.
3 Rigicon
* Newest entrant offering the Rigi10(TM) (malleable prosthesis) and Infla10(R) (inflatable prosthesis).
Market Segmentation Summary
Global Research Scope
Report Details:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
Quantitative Coverage:
Qualitative Coverage:
Data Sources:
Table of Contents
Men's reproductive health Device Market
List of Charts
List of Figures